Jacks Lee
Patrimonio netto: 416 433 $ in data 31/08/2026
Patrimonio netto: 416 433 $ in data 31/08/2026
Jacks Lee worked as Senior Vice President-Manufacturing & Supply at Merck & Co., Inc. from 2007 to 2023.
Served as Independent Director at G1 Therapeutics, Inc. from 2022 to 2024.
Served as Independent Director at Vaxcyte, Inc. from 2023 to 2026.
Education includes graduate degree from the University of Central Missouri and undergraduate degree from the University of Wisconsin.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/06/2026 | 6.856 ( 0% ) | 416 433 $ | 31/08/2026 |
| Società | Posizione | Fine |
|---|---|---|
| VAXCYTE, INC. | Direttore/Membro del Consiglio | 17/06/2026 |
| G1 THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 18/09/2024 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/06/2023 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
University of Central Missouri
University of Central Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
G1 Therapeutics, Inc.
G1 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for cancer treatment | Health Technology |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale